The global Tablet Clavulanic Acid Market is expected to register a steady revenue CAGR over the forecast period. Market revenue growth is primarily driven by use of the product in hospitals and drug stores as an effective antibiotic for the treatment of bacterial infections including sinus and respiratory tract infections.

Clavulanic acid is a Streptomyces-derived semisynthetic beta-lactamase inhibitor. Clavulanic acid has a beta-lactam ring and aggressively binds to beta-lactamase at or near its active site, inhibiting enzymatic activities. Other beta-lactam medicines are thus protected from beta-lactamase catalysis, driving their antibacterial properties. To treat infections caused by beta-lactamase generating organisms, this drug is used in concert with beta-lactamase susceptible antibiotics such as penicillin and cephalosporins. Preference for the product over other alternatives is attributed to its tendency of having relatively lesser effects on the weight and blood sugar levels of patients on whom it is administered.   

Top Companies Operating in the Global Tablet Clavulanic Acid Market:

  • GSK Pvt. Ltd. (U.K.)
  • Novartis Sandoz Group AG (Switzerland)
  • Sinopharm Sandwich Dayao Ye Ltd. (China)
  • Shandong New Time Pharmaceutical Ltd. (China)
  • Chemicals & Pharmaceuticals Ltd. (India)
  • United Laboratories Pvt. Ltd. (China)
  • CSPC Pharmaceutical Group Ltd. (China)
  • Sun Pharmaceutical Industries Ltd (U.S.)
  • North China Pharmaceutical Group Ltd. (China)
  • Medopharm Group Pvt. Ltd. (India)
  •  

Get a sample copy of the global Tablet Clavulanic Acid Market report, visit @ https://www.reportsanddata.com/sample-enquiry-form/5740

Major Factors Contributing to the Global Materials and Chemicals Market Revenue Growth

Rising prevalence of antibiotic medicines is a key factor expected to drive growth for the clavulanic market. Rise in demand for the product in the pharmaceutical industry is attributed to increasing cases of bacteria-driven diseases and a significant emphasis being laid on healthcare. The demand rise for the product is owing to increase in infections such as sinus infection, middle ear infection and lung respiratory tract infection, which primarily use clavulanic combined with amoxicillin for the treatments. Furthermore, the product is preferred owing to the quick effect seen on administering the dose leading to instant relief. The increased use of clavulanic in treating bacterial infections is a contributing factor to revenue growth of the market during the forecast period.     

 Table of Contents:

  1. Report Overview 
    1.1 Research Scope
    1.2 Key Tablet Clavulanic Acid Market segments
    1.3 Major players
    1.4 Market analysis by product type
    1.5 Market analysis by application
    1.6 Report timeline
  2. Global Growth Trends
    2.1 Global Tablet Clavulanic Acid Market size
    2.2 Latest regional market trends
    2.3 Emerging growth trends
  3. Competitive Outlook
    3.1 Global Tablet Clavulanic Acid Market key players
    3.2 Global Clavulanic Acid size by manufacturers
    3.3 Products of major players
    3.4 Entry barriers in the Tablet Clavulanic Acid Market
    3.5 Mergers, acquisitions, joint ventures, and other strategic alliances

Read full Report Description @ https://www.reportsanddata.com/report-detail/clavulanic-acid-market

Key Regional Markets Covered in the Report:

  • North America (U.S.A., Canada, Mexico)
  • Europe (Italy, U.K., Germany, France, Rest of Europe)
  • Asia Pacific (India, China, Japan, South Korea, Australia, Rest of Asia Pacific)
  • Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Tablet Clavulanic Acid Market Segmentation

Type Outlook (Revenue, USD Billion; 2019-2030)

  • Tablet
  • Capsule

Application/End-use Outlook (Revenue, USD Billion; 2019-2030)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

 Request a customized copy of the report @ https://www.reportsanddata.com/request-customization-form/5740

Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.  

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]

Blog: https://www.reportsanddata.com/blogs